LYSTEDA DIN 02401959
Health Canada record
| Active ingredient(s) | TRANEXAMIC ACID 650.0 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | B02AA02 TRANEXAMIC ACID |
| Original market date | |
| Current status date | 01-Sep-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Ferring Inc. — licence 100274, currently licensed, last inspection rating C (2026-05-19).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TRANEXAMIC ACID
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02064413 | CYKLOKAPRON 100 MG/ML | PFIZER CANADA ULC | Solution | TRANEXAMIC ACID 100 MG | Marketed |
| 02064405 | CYKLOKAPRON 500 MG | PFIZER CANADA ULC | Tablet | TRANEXAMIC ACID 500 MG | Marketed |
| 02409097 | GD-TRANEXAMIC ACID | GENMED A DIVISION OF PFIZER CANADA ULC | Tablet | TRANEXAMIC ACID 500 MG | Marketed |
| 02549395 | M-TRANEXAMIC ACID | MANTRA PHARMA INC | Tablet | TRANEXAMIC ACID 500 MG | Marketed |
| 02496232 | MAR-TRANEXAMIC ACID | MARCAN PHARMACEUTICALS INC | Tablet | TRANEXAMIC ACID 500 MG | Marketed |
| 02519194 | TRANEXAMIC ACID | JAMP PHARMA CORPORATION | Tablet | TRANEXAMIC ACID 500 MG | Marketed |
| 02392763 | TRANEXAMIC ACID INJECTION | OMEGA LABORATORIES LIMITED | Solution | TRANEXAMIC ACID 100 MG | Marketed |
| 02454785 | TRANEXAMIC ACID INJECTION | METHAPHARM INC | Solution | TRANEXAMIC ACID 100 MG | Approved |
| 02466015 | TRANEXAMIC ACID INJECTION | AURO PHARMA INC | Solution | TRANEXAMIC ACID 100 MG | Marketed |
| 02484846 | TRANEXAMIC ACID INJECTION | AURO PHARMA INC | Solution | TRANEXAMIC ACID 100 MG | Approved |
| 02484897 | TRANEXAMIC ACID INJECTION | AURO PHARMA INC | Solution | TRANEXAMIC ACID 100 MG | Approved |
| 02497328 | TRANEXAMIC ACID INJECTION | JAMP PHARMA CORPORATION | Solution | TRANEXAMIC ACID 100 MG | Marketed |
| 02531194 | TRANEXAMIC ACID INJECTION | EUGIA PHARMA INC. | Solution | TRANEXAMIC ACID 100 MG | Marketed |
| 02531208 | TRANEXAMIC ACID INJECTION | EUGIA PHARMA INC. | Solution | TRANEXAMIC ACID 100 MG | Marketed |
| 02531216 | TRANEXAMIC ACID INJECTION | EUGIA PHARMA INC. | Solution | TRANEXAMIC ACID 100 MG | Approved |
| 02246365 | TRANEXAMIC ACID INJECTION BP | SANDOZ CANADA INCORPORATED | Solution | TRANEXAMIC ACID 100 MG | Marketed |
| 02455900 | TRANEXAMIC ACID INJECTION BP | STRIDES PHARMA CANADA INC | Solution | TRANEXAMIC ACID 100 MG | Approved |
| 02505274 | TRANEXAMIC ACID INJECTION, USP | BAXTER CORPORATION | Solution | TRANEXAMIC ACID 500 MG | Approved |
| 02505282 | TRANEXAMIC ACID INJECTION, USP | BAXTER CORPORATION | Solution | TRANEXAMIC ACID 1000 MG | Approved |
| 02401231 | TRANEXAMIC ACID TABLETS | STERIMAX INC | Tablet | TRANEXAMIC ACID 500 MG | Marketed |
| 02457431 | ERFA-TRANEXAMIC | SEARCHLIGHT PHARMA INC | Solution | TRANEXAMIC ACID 100 MG | Cancelled Post Market |
| 02409089 | GD-TRANEXAMIC ACID | GENMED A DIVISION OF PFIZER CANADA ULC | Solution | TRANEXAMIC ACID 100 MG | Cancelled Pre Market |
| 02386933 | TRANEXAMIC ACID INJECTION BP | STERIMAX INC | Solution | TRANEXAMIC ACID 100 MG | Dormant |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 14080 | 2013-02-13 | New Drug Submission (NDS) |
International API supply for TRANEXAMIC ACID
8 valid EDQM Certificates of Suitability from 8 holders. 9 active FDA Drug Master Files.
Request a quote for LYSTEDA